-
1.INHIBITORS OF MCI-1 AS DRUGS TO OVERCOME RESISTANCE TO BRAF INHIBITORS AND MEK INHIBITORS 审中-公开
标题翻译: MCI-1作为药物的抑制剂对BRAF抑制剂和MEK抑制剂的耐药性公开(公告)号:WO2016200726A1
公开(公告)日:2016-12-15
申请号:PCT/US2016/036002
申请日:2016-06-06
IPC分类号: C07D211/16 , A61K31/445 , A61K38/16 , A61K39/395 , A61P35/00
CPC分类号: A61K31/4184 , A61K31/165 , A61K31/167 , A61K31/341 , A61K31/40 , A61K31/4025 , A61K31/405 , A61K31/4164 , A61K31/4178 , A61K31/4196 , A61K31/423 , A61K31/4245 , A61K31/433 , A61K31/437 , A61K31/4436 , A61K31/4439 , A61K31/444 , A61K31/445 , A61K31/4525 , A61K31/47 , A61K31/4709 , A61K31/495 , A61K31/496 , A61K31/4965 , A61K31/50 , A61K31/501 , A61K31/506 , A61K31/519 , A61K31/5375 , A61K31/5377 , A61K31/538 , A61K31/54 , A61K31/541 , A61K31/5415 , A61K45/06 , A61P35/00 , C07C233/87 , C07C237/00 , C07C237/52 , C07D207/337 , C07D209/08 , C07D209/42 , C07D211/34 , C07D215/48 , C07D217/06 , C07D233/60 , C07D235/10 , C07D235/12 , C07D235/16 , C07D235/28 , C07D249/12 , C07D263/34 , C07D265/36 , C07D279/02 , C07D295/108 , C07D307/54 , C07D317/60 , C07D401/06 , C07D403/06 , C07D403/14 , C07D405/06 , C07D409/14 , C07D413/06 , C07D417/12 , C07D487/04 , G01N33/5011 , G01N2333/4703 , A61K2300/00
摘要: The present invention includes compositions and methods for inhibiting MCL-1, including novel inhibitors of MCL-1, and compositions and methods for treating a subject with cancer that is refractory to one or more MAPK pathway protein inhibitors.
摘要翻译: 本发明包括用于抑制MCL-1的组合物和方法,包括MCL-1的新型抑制剂,以及用于治疗患有对一种或多种MAPK通路蛋白抑制剂难治的癌症的受试者的组合物和方法。